Exclusively for Qualified Medical Professionals & Clinics: Request Evaluation Dossier

Product Monograph

  • Product Name: Aspida Oral Sunscreen Tablets
  • Therapy: Systemic Cellular Photoprotection & Erythema Prevention
  • Category: Medical Nutraceuticals
  • Delivery: Oral Preventive Administration
  • Form: 3x1x10 Film-Coated Tablets (30 Tablets)
  • Compliance: Clinically Proven Botanical Actives / Non-Sedating
Aspida Oral Sunscreen Tablets Packshot
Official Packaging

Authentic Avixaa Aesthetiq Clinical Pack

Aspida Oral Sunscreen Tablets Packaging Showcase

ASPIDA Oral Sunscreen Tablets provide systemic dermatological protection from within, guarding vulnerable skin areas where topical sunscreen application is frequently missed, uneven, or washed away by perspiration.

Formulated with standardized Polypodium Leucotomos Extract (Phlebodium aureum) 480mg, synergized with Omega-3 Fatty Acids, Grape Seed Extract (100mg), Curcumin C3 Complex (50mg), Green Tea Polyphenols, Astaxanthin (4mg), and Vitamins C & E. This combination prevents UV-induced sunburn cell formation, preserves epidermal Langerhans immune cells, and prevents photo-provoked hyperpigmentation.

Primary Clinical Indications

Formulated to address specific dermatological indications requiring measurable physiological intervention:

  • Polymorphous Light Eruption (PMLE) and solar urticaria in photo-sensitive individuals.
  • Melasma patients prone to UV and visible-light induced hyperpigmentation relapses.
  • Athletes, outdoor professionals, and travelers exposed to intense solar radiation.
  • Complementary cellular protection alongside daily topical sunscreen protocols.

Active Botanical & Nutrient Profile

Polypodium Leucotomos (Phlebodium aureum) Extract 480 mg, Omega-3 Fatty Acids, Grape Seed Extract (95% Proanthocyanidins) 100 mg, Curcumin C3 Complex® 50 mg, Green Tea Extract (EGCG) 100 mg, Natural Astaxanthin 4 mg, Ascorbic Acid 100 mg, d-Alpha Tocopherol 50 IU.

Recommended Administration & Dosage

1 Tablet daily in the morning, 30 minutes prior to outdoor sun exposure. During periods of prolonged intense sun exposure, a second tablet may be consumed 4 hours later.

Synergistic Companion Therapy
Aspida Advanced Sun Protection (Topical)

Broad-spectrum SPF 50+ PA++++ Gel/Cream to create an impenetrable external barrier alongside internal systemic tablets.

View Monograph

Aspida Advanced Sun Protection (Topical)

Clinical Evaluation & Results

Clinical dermatological studies show a 76% reduction in minimal erythema dose (MED) sensitivity and significant inhibition of UV-induced matrix metalloproteinase-1 (MMP-1) expression.

84%

Erythema Minimization

Systemic reduction in ultraviolet-induced skin redness and burn.

91%

Oxidative Quenching

High-potency botanical polyphenol radical neutralization.

88%

Photoprotection Synergism

Complements topical sunscreen against deep systemic photoaging.